-PTI The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of 43 formulation packs including drugs such as the antibiotic ciprofloxacin, BCG vaccine and the anti-diabetic metformin. "The prices have been fixed / revised in respect of 43 formulation packs, both ceiling and retail price packs, under DPCO, 2013," NPPA said. According to the drug price regulator the manufacturers selling the 43 drugs at maximum retail price higher than the ceiling price...

-The Times of India MUMBAI: In a move that has surprised and shaken the industry, prices of widely-used expensive anti-diabetic and cardiac medicines will reduce by as much as 35% over the next few weeks, with the drug pricing regulator, National Pharmaceutical Pricing Authority (NPPA), deciding to bring them under price control. In a rare invocation of a lesser-used provision in the Drug Price Control Order (DPCO), NPPA has fixed the prices...

-The Business Standard   Regulator studying pricing models in various nations; draft legislation likely by end of March Pharmaceutical companies might be up for stricter price regulations. The government is planning to bring in a legislation that would take into consideration pricing models across the US, European Union (EU), China and 14 Organisation for Economic Co-operation and Development (OECD) countries. The National Pharmaceutical Pricing Authority (NPPA), which regulates prices of medicines in the market,...

-Down to Earth Nearly 83 per cent medicines out of the ambit of price control policy, thus making them out of reach for most patients, say two recent reports Indicating failure of the National Pharmaceutical Pricing Policy (NPPP), 2012 and the Drugs Price Control Order (DPCO), 2013, two recently-released reports have stated that medicines are still not accessible and affordable for the citizens of the country. The reports that were jointly released...

-The Telegraph New Delhi: The rules for price caps on 348 medicines imposed by the central government last year provide drug companies "escape routes" and promise little relief to consumers, a report released today has warned. The report from the Public Health Foundation of India (PHFI), an academic institution, has also cautioned that the Drug Price Control Order (DPCO) rules will encourage the growth of irrational combinations of drugs that remain outside...